$CHCI
Comstock Holding Companies, Inc. Stock $chci

$chci Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000129996922000013 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$7.765M	$31.09M	$8.000M
YoY Change	-2.94%	38.27%	-24.53%
Cost Of Revenue	$6.374M	$24.65M	$6.500M
YoY Change	-1.94%	33.64%	-22.62%
Gross Profit	$1.391M	$6.444M	$1.400M
YoY Change	-0.64%	59.43%	-36.36%
Gross Profit Margin	17.91%	20.72%	17.5%
Selling, General & Admin	$304.0K	$1.285M	$800.0K
YoY Change	-62.0%	-2.21%	33.33%
% of Gross Profit	21.85%	19.94%	57.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$29.00K	$94.00K	$0.00
YoY Change		-6.0%	-100.0%
% of Gross Profit	2.08%	1.46%	0.0%
Operating Expenses	$398.0K	$1.285M	$900.0K
YoY Change	-55.78%	-2.21%	50.0%
Operating Profit	$993.0K	$5.065M	$500.0K
YoY Change	98.6%	90.84%	-68.75%
Interest Expense	$95.00K	-$249.0K	-$100.0K
YoY Change	-195.0%	-58.5%	0.0%
% of Operating Profit	9.57%	-4.92%	-20.0%
Other Income/Expense, Net	-$73.00K	$6.000K	$0.00
YoY Change		-62.5%	-100.0%
Pretax Income	$1.015M	$4.822M	$500.0K
YoY Change	103.0%	122.62%	-70.59%
Income Tax	$72.00K	-$11.22M	$0.00
% Of Pretax Income	7.09%	-232.62%	0.0%
Net Earnings	-$763.0K	$13.61M	$500.0K
YoY Change	-252.6%	553.65%	-70.59%
Net Earnings / Revenue	-9.83%	43.77%	6.25%
Basic Earnings Per Share		$1.66
Diluted Earnings Per Share	-$92.63K	$1.50	$56.18K
COMMON SHARES
Basic Shares Outstanding		8.213M shares
Diluted Shares Outstanding		9.095M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.82M	$15.82M	$7.000M
YoY Change	126.04%	126.04%	100.0%
Cash & Equivalents	$15.82M	$15.82M	$7.032M
Short-Term Investments
Other Short-Term Assets	$197.0K	$197.0K	$200.0K
YoY Change	-1.5%	-1.5%	-33.33%
Inventory
Prepaid Expenses
Receivables	$46.00K		$62.00K
Other Receivables			$0.00
Total Short-Term Assets	$20.08M	$16.02M	$12.33M
YoY Change	62.89%	30.24%	32.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$264.0K	$7.509M	$170.0K
YoY Change	55.29%	-8.43%	-38.85%
Goodwill			$1.700M
YoY Change			0.0%
Intangibles	$0.00
YoY Change
Long-Term Investments	$4.702M	$4.702M	$6.300M
YoY Change	-25.37%	-25.37%	-25.0%
Other Assets	$15.36M	$15.36M
YoY Change
Total Long-Term Assets	$23.53M	$27.58M	$16.25M
YoY Change	44.74%	69.21%	53.08%
TOTAL ASSETS
Total Short-Term Assets	$20.08M	$16.02M	$12.33M
Total Long-Term Assets	$23.53M	$27.58M	$16.25M
Total Assets	$43.60M	$43.60M	$28.58M
YoY Change	52.57%	52.45%	43.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$783.0K	$783.0K	$523.0K
YoY Change	49.71%	56.6%	-63.63%
Accrued Expenses	$10.83M	$10.83M	$964.0K
YoY Change	1023.34%	-4.17%	480.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$5.000K
YoY Change	-100.0%		-93.51%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.061M	$11.61M	$4.503M
YoY Change	34.6%	-1.59%	-56.29%
LONG-TERM LIABILITIES
Long-Term Debt	$5.500M	$5.500M	$5.500M
YoY Change	0.0%	0.0%	358.33%
Other Long-Term Liabilities	$1.194M	$1.194M
YoY Change
Total Long-Term Liabilities	$6.694M	$6.694M	$5.500M
YoY Change	21.71%	21.71%	358.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.061M	$11.61M	$4.503M
Total Long-Term Liabilities	$6.694M	$6.694M	$5.500M
Total Liabilities	$18.31M	$18.31M	$17.36M
YoY Change	5.43%	5.21%	50.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$179.5M		-$193.1M
YoY Change	-7.05%		-1.07%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.662M		$2.662M
YoY Change	0.0%
Treasury Stock Shares	86.00K shares		86.00K shares
Shareholders Equity	$25.30M	$25.30M	$11.22M
YoY Change
Total Liabilities & Shareholders Equity	$43.60M	$43.60M	$28.58M
YoY Change	52.57%	52.45%	43.38%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$763.0K	$13.61M	$500.0K
YoY Change	-252.6%	553.65%	-70.59%
Depreciation, Depletion And Amortization	$29.00K	$94.00K	$0.00
YoY Change		-6.0%	-100.0%
Cash From Operating Activities	$4.856M	$8.688M	$700.0K
YoY Change	593.71%	142.75%	-53.33%
INVESTING ACTIVITIES
Capital Expenditures	-$97.00K	-$188.0K	$0.00
YoY Change		88.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$2.023M	$1.428M	$1.800M
YoY Change	12.39%	-20.67%	350.0%
Cash From Investing Activities	$1.926M	$1.276M	$1.800M
YoY Change	7.0%	-25.07%	800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-13.00K	-$227.0K	0.000
YoY Change		-19.5%	-100.0%
NET CHANGE
Cash From Operating Activities	4.856M	$8.688M	700.0K
Cash From Investing Activities	1.926M	$1.276M	1.800M
Cash From Financing Activities	-13.00K	-$227.0K	0.000
Net Change In Cash	6.769M	$8.791M	2.500M
YoY Change	170.76%	149.67%	-162.5%
FREE CASH FLOW
Cash From Operating Activities	$4.856M	$8.688M	$700.0K
Capital Expenditures	-$97.00K	-$188.0K	$0.00
Free Cash Flow	$4.953M	$8.876M	$700.0K
YoY Change	607.57%	141.26%	-56.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001299969
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M26D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M12D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2021	chci	Change In Ownership Of Shareholders In Specified Time ChangeInOwnershipOfShareholdersInSpecifiedTime	P3Y
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-32375
CY2021	dei	Entity Registrant Name EntityRegistrantName	Comstock Holding Companies, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 Reston Metro Plaza
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	10th Floor
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Reston
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1164345
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20190
CY2021	dei	City Area Code CityAreaCode	703
CY2021	dei	Local Phone Number LocalPhoneNumber	230-1985
CY2021	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value
CY2021	dei	Trading Symbol TradingSymbol	CHCI
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	16094232	USD
CY2021	dei	Auditor Firm AuditorFirmId	248
CY2021	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2021	dei	Auditor Location AuditorLocation	Arlington, Virginia
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15823000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7032000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	62000	USD
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1697000	USD
CY2020Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	3568000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	197000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	186000	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2313000	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1477000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20076000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	12325000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	264000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	170000	USD
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	4702000	USD
CY2020Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	6307000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7245000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7914000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	15000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	29000	USD
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	1834000	USD
CY2021Q4	us-gaap	Assets Assets	43602000	USD
CY2020Q4	us-gaap	Assets Assets	28579000	USD
CY2021Q4	chci	Accrued Personnel Costs AccruedPersonnelCosts	3468000	USD
CY2020Q4	chci	Accrued Personnel Costs AccruedPersonnelCosts	2333000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	783000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	854000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	616000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	569000	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5000	USD
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1194000	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	742000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6061000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4503000	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	5500000	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	5500000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6745000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7361000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	18306000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	17364000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200617000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200147000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	86000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	86000	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2662000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1400000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2662000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-179507000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-193116000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25296000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11215000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43602000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28579000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31093000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22487000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	24649000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	18445000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1285000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1314000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	94000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	74000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	26028000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	19833000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	5065000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	2654000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-235000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-344000	USD
CY2021	chci	Change In Fair Value Of Equity Method Investment ChangeInFairValueOfEquityMethodInvestment	14000	USD
CY2020	chci	Change In Fair Value Of Equity Method Investment ChangeInFairValueOfEquityMethodInvestment	160000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4822000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2166000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11217000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	16039000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2141000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2430000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-59000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	13609000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2082000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8213000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8056000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9095000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8539000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.95
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.27
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.29
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.66
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.76
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.25
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.26
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.50
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	8357000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	776000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2082000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11215000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-250000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	722000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	13609000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25296000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	16039000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2141000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	633000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	701000	USD
CY2021	chci	Gain Loss On Equity Method Investments Carried At Fair Value GainLossOnEquityMethodInvestmentsCarriedAtFairValue	-14000	USD
CY2020	chci	Gain Loss On Equity Method Investments Carried At Fair Value GainLossOnEquityMethodInvestmentsCarriedAtFairValue	-160000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	103000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	11300000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1886000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-82000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	50000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1135000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-409000	USD
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-41000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	52000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-239000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-699000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8688000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3579000	USD
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2058000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	3522000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	1818000	USD
CY2021	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	188000	USD
CY2020	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	115000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1276000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1703000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	121000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5554000	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	126000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5782000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	222000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	54000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-227000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-282000	USD
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-881000	USD
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-145000	USD
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-36000	USD
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-33000	USD
CY2021	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-29000	USD
CY2020	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-1301000	USD
CY2021	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-946000	USD
CY2020	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-1479000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8791000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3521000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7032000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3511000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15823000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7032000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	234000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	397000	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	28000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	68000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	50000	USD
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2020	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	1954000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	8023000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Significant items subject to such estimates, include, but are not limited to, the analysis of goodwill impairment, the valuation of equity method investments, and the valuation of deferred tax assets. Assumptions made in the development of these estimates contemplate the macroeconomic landscape and the Company's anticipated results, however actual results may differ materially from these estimates.
CY2021	us-gaap	Fiscal Period FiscalPeriod	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comstock uses a fiscal reporting calendar which begins on January 1 and ends on December 31. The fiscal years presented are the years ended December 31, 2021 (“2021”) and December 31, 2020 (“2020”). Each of the Company’s fiscal quarters ends on the last day of the calendar month.</span></div>
CY2021Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	300000	USD
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1700000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1275000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1087000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1011000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	917000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	264000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	170000	USD
CY2021	us-gaap	Depreciation Depreciation	100000	USD
CY2020	us-gaap	Depreciation Depreciation	100000	USD
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	4702000	USD
CY2020Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	6307000	USD
CY2021Q4	chci	Proceed From Sale Of Investment Percentage Of Profit ProceedFromSaleOfInvestmentPercentageOfProfit	0.50
CY2021	chci	Proportionate Share Of Net Income And Distributions Amount ProportionateShareOfNetIncomeAndDistributionsAmount	100000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	895000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	623000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	318000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	116000	USD
CY2021	us-gaap	Lease Cost LeaseCost	1213000	USD
CY2020	us-gaap	Lease Cost LeaseCost	739000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	569000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	92000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y9M29D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0425
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	5500000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	5505000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	917000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	939000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	961000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	984000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1008000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4091000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8900000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1539000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7361000	USD
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	USD
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	5000	USD
CY2021Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	5500000	USD
CY2020Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	5500000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5500000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5500000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	600000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	700000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	900000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	436000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.81
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M26D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	424000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	24000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.14
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.84
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	397000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.89
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	998000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	335000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.01
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	836000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31093000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22487000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31093000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22487000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31093000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22487000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	104000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	104000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	358000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-143000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1302000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-26000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1660000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-169000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-12981000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	194000	USD
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-11217000	USD
CY2020	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	25000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0517
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0493
CY2021	chci	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0108
CY2020	chci	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.2216
CY2021	chci	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	0.0000
CY2020	chci	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	0.0079
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2.6600
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0825
CY2021	chci	Effective Income Tax Rate Reconciliation Current State Income Taxes EffectiveIncomeTaxRateReconciliationCurrentStateIncomeTaxes	-0.0026
CY2020	chci	Effective Income Tax Rate Reconciliation Current State Income Taxes EffectiveIncomeTaxRateReconciliationCurrentStateIncomeTaxes	-0.1316
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0855
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0150
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-2.3262
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0115
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	34773000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	37899000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	485000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	648000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	1335000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	1192000	USD
CY2021Q4	chci	Deferred Tax Assets Right Of Use Lease Liability DeferredTaxAssetsRightOfUseLeaseLiability	1935000	USD
CY2020Q4	chci	Deferred Tax Assets Right Of Use Lease Liability DeferredTaxAssetsRightOfUseLeaseLiability	2057000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	917000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	37000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	362000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	9000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26599000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39708000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13208000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2134000	USD
CY2021Q4	chci	Deferred Tax Liabilities Right Of Use Lease Asset DeferredTaxLiabilitiesRightOfUseLeaseAsset	1904000	USD
CY2020Q4	chci	Deferred Tax Liabilities Right Of Use Lease Asset DeferredTaxLiabilitiesRightOfUseLeaseAsset	2052000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	103000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1908000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2155000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21000	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	139000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	16039000	USD
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2141000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2430000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-59000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8213000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8056000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	882000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	483000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9095000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8539000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.95
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.27
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.29
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.66
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.76
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.25
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.26
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.50
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.03
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.03
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000	USD

Files In Submission

Name	View Source	Status
0001299969-22-000013-index-headers.html	Edgar Link	pending
0001299969-22-000013-index.html	Edgar Link	pending
0001299969-22-000013.txt	Edgar Link	pending
0001299969-22-000013-xbrl.zip	Edgar Link	pending
chci-20211231.htm	Edgar Link	pending
chci-20211231.xsd	Edgar Link	pending
chci-20211231_cal.xml	Edgar Link	unprocessable
chci-20211231_def.xml	Edgar Link	unprocessable
chci-20211231_htm.xml	Edgar Link	completed
chci-20211231_lab.xml	Edgar Link	unprocessable
chci-20211231_pre.xml	Edgar Link	unprocessable
chci-ex2112021xq4.htm	Edgar Link	pending
chci-ex2312021xq4.htm	Edgar Link	pending
chci-ex3112021xq4.htm	Edgar Link	pending
chci-ex3122021xq4.htm	Edgar Link	pending
chci-ex3212021xq4.htm	Edgar Link	pending
ex102220190701bellacolli.htm	Edgar Link	pending
ex102220190701bellacolli001.jpg	Edgar Link	pending
ex102220190701bellacolli002.jpg	Edgar Link	pending
ex102220190701bellacolli003.jpg	Edgar Link	pending
ex102220190701bellacolli004.jpg	Edgar Link	pending
ex102220190701bellacolli005.jpg	Edgar Link	pending
ex102220190701bellacolli006.jpg	Edgar Link	pending
ex102220190701bellacolli007.jpg	Edgar Link	pending
ex102220190701bellacolli008.jpg	Edgar Link	pending
ex102220190701bellacolli009.jpg	Edgar Link	pending
ex102220190701bellacolli010.jpg	Edgar Link	pending
ex10302021_1020xuptonxco.htm	Edgar Link	pending
ex10302021_1020xuptonxco001.jpg	Edgar Link	pending
ex10302021_1020xuptonxco002.jpg	Edgar Link	pending
ex10302021_1020xuptonxco003.jpg	Edgar Link	pending
ex10302021_1020xuptonxco004.jpg	Edgar Link	pending
ex10302021_1020xuptonxco005.jpg	Edgar Link	pending
ex10302021_1020xuptonxco006.jpg	Edgar Link	pending
ex10302021_1020xuptonxco007.jpg	Edgar Link	pending
ex10302021_1020xuptonxco008.jpg	Edgar Link	pending
ex10302021_1020xuptonxco009.jpg	Edgar Link	pending
ex10302021_1020xuptonxco010.jpg	Edgar Link	pending
ex10302021_1020xuptonxco011.jpg	Edgar Link	pending
ex10302021_1020xuptonxco012.jpg	Edgar Link	pending
ex10302021_1020xuptonxco013.jpg	Edgar Link	pending
ex10302021_1020xuptonxco014.jpg	Edgar Link	pending
ex10302021_1020xuptonxco015.jpg	Edgar Link	pending
ex10302021_1020xuptonxco016.jpg	Edgar Link	pending
ex10302021_1020xuptonxco017.jpg	Edgar Link	pending
ex10302021_1020xuptonxco018.jpg	Edgar Link	pending
ex10302021_1020xuptonxco019.jpg	Edgar Link	pending
ex10302021_1020xuptonxco020.jpg	Edgar Link	pending
ex10302021_1020xuptonxco021.jpg	Edgar Link	pending
ex10302021_1020xuptonxco022.jpg	Edgar Link	pending
ex10302021_1020xuptonxco023.jpg	Edgar Link	pending
ex10302021_1020xuptonxco024.jpg	Edgar Link	pending
ex10302021_1020xuptonxco025.jpg	Edgar Link	pending
ex103120211103ivyzelmanc.htm	Edgar Link	pending
ex103120211103ivyzelmanc001.jpg	Edgar Link	pending
ex103120211103ivyzelmanc002.jpg	Edgar Link	pending
ex103120211103ivyzelmanc003.jpg	Edgar Link	pending
ex103120211103ivyzelmanc004.jpg	Edgar Link	pending
ex42exdescriptionofsecur.htm	Edgar Link	pending
ex42exdescriptionofsecur001.jpg	Edgar Link	pending
ex42exdescriptionofsecur002.jpg	Edgar Link	pending
ex42exdescriptionofsecur003.jpg	Edgar Link	pending
ex42exdescriptionofsecur004.jpg	Edgar Link	pending
ex42exdescriptionofsecur005.jpg	Edgar Link	pending
ex42exdescriptionofsecur006.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHCI
Comstock Holding Companies, Inc. Stock $chci

2021 Q4 Form 10-K Financial Statement

#000129996922000013 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCI Comstock Holding Companies, Inc. Stock $chci

2021 Q4 Form 10-K Financial Statement

#000129996922000013 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCI
Comstock Holding Companies, Inc. Stock $chci